scholarly article | Q13442814 |
P2093 | author name string | F Kullmann | |
W Dietmaier | |||
R Fishel | |||
J Rüschoff | |||
T Bocker | |||
S Wallinger | |||
P433 | issue | 21 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microsatellite | Q265193 |
DNA mismatch repair | Q2984243 | ||
diagnosis | Q16644043 | ||
P304 | page(s) | 4749-4756 | |
P577 | publication date | 1997-11-01 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression | |
P478 | volume | 57 |
Q50558566 | 3'-UTR poly(T/U) repeat of EWSR1 is altered in microsatellite unstable colorectal cancer with nearly perfect sensitivity. |
Q35967127 | 5,10-methylenetetrahydrofolate reductase 677 and 1298 polymorphisms, folate intake, and microsatellite instability in colon cancer |
Q43199969 | A missense mutation in both hMSH2 and APC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening |
Q34720965 | A novel approach for characterizing microsatellite instability in cancer cells |
Q37592779 | A novel germline POLE mutation causes an early onset cancer prone syndrome mimicking constitutional mismatch repair deficiency. |
Q35013990 | A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory |
Q89723592 | A slipped-CAG DNA-binding small molecule induces trinucleotide-repeat contractions in vivo |
Q33501737 | AP-2alpha induces epigenetic silencing of tumor suppressive genes and microsatellite instability in head and neck squamous cell carcinoma |
Q57338061 | Aberrant protein expression and frequent allelic loss of MSH3 in colorectal cancer with low-level microsatellite instability |
Q35753544 | Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences |
Q36507457 | Accuracy of MSI testing in predicting germline mutations of MSH2 and MLH1: a case study in Bayesian meta-analysis of diagnostic tests without a gold standard |
Q61455092 | Accurate diagnosis of mismatch repair deficiency in colorectal cancer using high-quality DNA samples from cultured stem cells |
Q36694101 | Activity (transcription) of the genes for MLH1, MSH2 and p53 in sporadic colorectal tumours with micro-satellite instability |
Q33636690 | Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: a study from the colon cancer family registry |
Q49835484 | Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer |
Q88581394 | Analysis of Syndecan-2 Methylation in Bowel Lavage Fluid for the Detection of Colorectal Neoplasm |
Q77309671 | Analysis of allelic imbalance in patients with colorectal cancer according to stage and presence of synchronous liver metastases |
Q37307618 | Analysis of microsatellite instability in colorectal carcinoma by microfluidic-based chip electrophoresis |
Q37395329 | Analysis of microsatellite instability in medulloblastoma |
Q36309767 | Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection |
Q24539206 | Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. |
Q38760793 | Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma |
Q74126803 | Automated fluorescent detection of microsatellite instability |
Q33868608 | BRAF, K-ras and BAT26 mutations in colorectal polyps and stool. |
Q42856658 | Biological significance of microsatellite instability-low (MSI-L) status in colorectal tumors |
Q36340108 | Biomarkers and the genetics of early neoplastic lesions |
Q34205596 | Biomarkers for Colorectal Cancer |
Q54525841 | Carcinogenesis and hereditart colon cancers |
Q37238532 | Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways |
Q34659119 | Chemotherapy induced microsatellite instability and loss of heterozygosity in chromosomes 2, 5, 10, and 17 in solid tumor patients. |
Q42134566 | Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair |
Q48775299 | Clinical Impact of Mismatch Repair Protein Testing on Outcome of Early Staged Colorectal Carcinomas |
Q35198210 | Clinical significance of mismatch repair genes immunohistochemical expression of complex endometrial hyperplasia |
Q53334151 | Clinicopathologic and immunohistochemistry characterization of synchronous multiple primary gastric adenocarcinoma. |
Q36415689 | Clinicopathological and molecular genetic analysis of 4 typical Chinese HNPCC families. |
Q36135867 | Clinicopathological and patient characteristics of early gastric neoplasia endoscopically resected with loss of Mlh1 expression |
Q34138105 | Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans. |
Q42229907 | Colorectal Cancer Screening: A Comprehensive Review to Recent Non-Invasive Methods |
Q33729779 | Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of origin |
Q43087042 | Colorectal neoplasia in acromegaly |
Q33732288 | Colorectal tumour microsatellite instability test results: perspectives from patients |
Q91775943 | Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer |
Q95786148 | Comparative genetic analysis of metachronous anaplastic oligoastrocytomas with extended recurrence-free interval |
Q62937164 | Comparison of three commonly used PCR-based techniques to analyze MSI status in sporadic colorectal cancer |
Q37385768 | Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases |
Q33829127 | Constitutional mismatch repair deficiency and childhood leukemia/lymphoma--report on a novel biallelic MSH6 mutation |
Q36351328 | CpG island methylator phenotype-positive tumors in the absence of MLH1 methylation constitute a distinct subset of duodenal adenocarcinomas and are associated with poor prognosis. |
Q39860943 | CpG methylation modifies the genetic stability of cloned repeat sequences |
Q37229443 | DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? |
Q46778172 | Does mutation of transforming growth factor-beta type II receptor gene play an important role in colorectal polyps? |
Q80149645 | Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch repair gene expression in prostate cancer |
Q34441207 | Evidence that hMLH3 functions primarily in meiosis and in hMSH2-hMSH3 mismatch repair. |
Q36246478 | Evolution of the nomenclature for the hereditary colorectal cancer syndromes |
Q36641429 | Extensive molecular screening for hereditary non-polyposis colorectal cancer |
Q35023943 | Frequency of mismatch repair deficiency in ovarian cancer: a systematic review This article is a US Government work and, as such, is in the public domain of the United States of America |
Q36617588 | Frequent loss of heterozygosity at the DNA mismatch-repair loci hMLH1 and hMSH3 in sporadic breast cancer |
Q51284026 | Frequent microsatellite instability in papillary and solid-type, poorly differentiated adenocarcinomas of the stomach. |
Q29395710 | Genetic Instability Caused by Loss of MutS Homologue 3 in Human Colorectal Cancer |
Q41707387 | Genetic alterations in ulcerative colitis-associated neoplasia focusing on APC, K-ras gene and microsatellite instability |
Q35810106 | Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers |
Q35355359 | Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas |
Q47767718 | Geno- and pheno-typic characterization in ten patients with double-primary gastric and colorectal adenocarcinomas |
Q36144711 | Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition. |
Q35787099 | Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia |
Q33939068 | Genotype to phenotype: analyzing the effects of inherited mutations in colorectal cancer families |
Q83879718 | Germline mutations of the hMLH1 and hMSH2 mismatch repair genes in Belgian hereditary nonpolyposis colon cancer (HNPCC) patients |
Q34098053 | Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progression |
Q39693250 | Harnessing mismatch repair to model sporadic cancers |
Q35355789 | Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis |
Q35597944 | Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer |
Q34396531 | High incidence of microsatellite instability and loss of heterozygosity in three loci in breast cancer patients receiving chemotherapy: a prospective study |
Q35787046 | High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability |
Q35746344 | Histopathological identification of colon cancer with microsatellite instability |
Q34107260 | Human pluripotent stem cells have a novel mismatch repair-dependent damage response |
Q36812749 | Human postmeiotic segregation 2 exhibits biased repair at tetranucleotide microsatellite sequences |
Q28390025 | Humans accumulate microsatellite instability with acquired loss of MLH1 protein in hematopoietic stem and progenitor cells as a function of age |
Q33948312 | Hypermutability at a poly(A/T) tract in the human germline |
Q36289304 | IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal Cancers |
Q38873106 | Immunohistochemical expression pattern of MMR protein can specifically identify patients with colorectal cancer microsatellite instability |
Q36492931 | Immunohistochemistry and microsatellite instability analysis in molecular subtyping of colorectal carcinoma based on mismatch repair competency |
Q36734614 | Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing |
Q37239487 | Infrequent loss of heterozygosity of APC/MCC and DCC genes in gastric cancer showing DNA microsatellite instability |
Q35842039 | Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer |
Q28269118 | Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis |
Q34579284 | Is reduced expression of mismatch repair genes MLH1 and MSH2 in patients with sporadic colorectal cancer related to their prognosis? |
Q36628524 | KRAS G>A mutation favors poor tumor differentiation but may not be associated with prognosis in patients with curatively resected duodenal adenocarcinoma. |
Q34643960 | KRAS mutation testing in metastatic colorectal cancer |
Q35587940 | Ki-ras gene mutations, LOH of the APC and DCC genes, and microsatellite instability in primary colorectal carcinoma are not associated with micrometastases in pericolonic lymph nodes or with patients' survival |
Q83821428 | Lack of association between microsatellite instability and benign adrenal tumors |
Q35669158 | Lethal Mutagenesis: Targeting the Mutator Phenotype in Cancer |
Q34604636 | Loss of heterozygosity: an independent prognostic factor of colorectal cancer |
Q30495565 | Low frequency of replication errors in primary nervous system tumours |
Q35597157 | Low level microsatellite instability may be associated with reduced cancer specific survival in sporadic stage C colorectal carcinoma |
Q49111534 | Low-level microsatellite instability phenotype in sporadic glioblastoma multiforme |
Q33653935 | Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening |
Q34500446 | MSH3-deficiency initiates EMAST without oncogenic transformation of human colon epithelial cells |
Q36137083 | Methylation of MGMT Is Associated with Poor Prognosis in Patients with Stage III Duodenal Adenocarcinoma. |
Q31164885 | Microsatellite analysis of hereditary nonpolyposis colorectal cancer-associated colorectal adenomas by laser-assisted microdissection: correlation with mismatch repair protein expression provides new insights in early steps of tumorigenesis |
Q35836697 | Microsatellite analysis of pleural supernatants could increase sensitivity of pleural fluid cytology |
Q35589116 | Microsatellite instability and gastric non-invasive neoplasia in a high risk population in Cesena, Italy. |
Q36646020 | Microsatellite instability and intratumoural heterogeneity in 100 right-sided sporadic colon carcinomas |
Q37269648 | Microsatellite instability and loss of heterozygosity detected in middle-aged patients with sporadic colon cancer: A retrospective study. |
Q44201536 | Microsatellite instability and loss of heterozygosity of tumor suppressor genes in Bosnian patients with sporadic colorectal cancer |
Q42112990 | Microsatellite instability and mismatch repair gene inactivation in sporadic pancreatic and colon tumours |
Q35753493 | Microsatellite instability and mutation of DNA mismatch repair genes in gliomas. |
Q87065266 | Microsatellite instability and promoter hypermethylation in colorectal cancer in India |
Q92645700 | Microsatellite instability and protein expression of MLH1 and MSH2 genes in young Mexican patients less than 50 years of age diagnosed with colorectal cancer |
Q35363901 | Microsatellite instability and the clinicopathological features of sporadic colorectal cancer |
Q33757624 | Microsatellite instability at tetranucleotide repeats in sporadic colorectal cancer in Japan. |
Q24627393 | Microsatellite instability in colorectal cancer |
Q36616694 | Microsatellite instability in patients with chronic B-cell lymphocytic leukaemia |
Q35557578 | Microsatellite instability in patients with multiple primary cancers of the gastrointestinal tract |
Q55264193 | Microsatellite instability in prostate cancer by PCR or next-generation sequencing. |
Q36619549 | Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor |
Q44003216 | Microsatellite instability testing in Korean patients with colorectal cancer |
Q55083967 | Microsatellite instability testing in colorectal cancer using the QiaXcel advanced platform. |
Q36618286 | Microsatellite instability, Epstein-Barr virus, mutation of type II transforming growth factor beta receptor and BAX in gastric carcinomas in Hong Kong Chinese |
Q42914163 | Microsatellite instability. A new predictive marker (?) |
Q36623156 | Minisatellite instability is found in colorectal tumours with mismatch repair deficiency |
Q64922689 | Mismatch Repair/Microsatellite Instability Testing Practices among US Physicians Treating Patients with Advanced/Metastatic Colorectal Cancer. |
Q34077139 | Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaks |
Q36475458 | Mismatch repair hMSH2, hMLH1, hMSH6 and hPMS2 mRNA expression profiles in precancerous and cancerous urothelium |
Q35057393 | Mismatch repair protein expression in colorectal cancer |
Q24612859 | Modulation of mismatch repair and genomic stability by miR-155 |
Q39381552 | Molecular Biomarkers of Colorectal Cancer and Cancer Disparities: Current Status and Perspective |
Q35745947 | Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma |
Q60958385 | Molecular and Computational Methods for the Detection of Microsatellite Instability in Cancer |
Q37360286 | Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant |
Q25257401 | Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis |
Q28363159 | Molecular predictors of survival after adjuvant chemotherapy for colon cancer |
Q35433209 | Mononucleotide microsatellite instability and germline MSH6 mutation analysis in early onset colorectal cancer |
Q31920327 | Multiple mutation analyses in single tumor cells with improved whole genome amplification |
Q30444930 | Origin of microsatellite instability in gastric cancer |
Q41965413 | Pathogenesis of non-familial colorectal carcinomas with high microsatellite instability |
Q37852615 | Phenotype-genotype correlation in familial breast cancer |
Q35787776 | Polymorphic variation at the BAT-25 and BAT-26 loci in individuals of African origin. Implications for microsatellite instability testing |
Q33188136 | Possible alternative carcinogenesis pathway featuring microsatellite instability in colorectal cancer stroma |
Q36882484 | Prediction of germline mutations and cancer risk in the Lynch syndrome |
Q43894713 | Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group |
Q34633911 | Prevalence of pathological germline mutations of hMLH1 and hMSH2 genes in colorectal cancer |
Q37173288 | Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer. |
Q24603535 | Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas |
Q37834463 | Prophylactic surgery in Lynch syndrome |
Q35594413 | Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation |
Q34801092 | Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry |
Q90720634 | Recent Advances in the Clinical Development of Immune Checkpoint Blockade Therapy for Mismatch Repair Proficient (pMMR)/non-MSI-H Metastatic Colorectal Cancer |
Q60689140 | Reduced mRNA expression in paraffin-embedded tissue identifies MLH1- and MSH2-deficient colorectal tumours and potential mutation carriers |
Q53998721 | Relationship between grade of microsatellite instability and target genes of mismatch repair pathways in sporadic colorectal carcinoma. |
Q33905608 | Replication Inhibitors Modulate Instability of an Expanded Trinucleotide Repeat at the Myotonic Dystrophy Type 1 Disease Locus in Human Cells |
Q24618618 | Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability |
Q24806345 | Role of APC and DNA mismatch repair genes in the development of colorectal cancers |
Q37147224 | Sampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer |
Q92839298 | Screening of MSI detection loci and their heterogeneity in East Asian colorectal cancer patients |
Q93026501 | Sequencing-based microsatellite instability testing using as few as six markers for high-throughput clinical diagnostics |
Q36108299 | Somatic gene mutations in African Americans may predict worse outcomes in colorectal cancer |
Q53323763 | Sporadic colon cancer: mismatch repair immunohistochemistry and microsatellite instability in Omani subjects. |
Q83450510 | Sporadic colorectal carcinomas with low-level microsatellite instability: a distinct subgroup with specific clinicopathological and molecular features |
Q41127019 | Subclonal analysis in a lobular breast cancer with classical and solid growth pattern mimicking a solid-papillary carcinoma |
Q24796574 | Systemic chemotherapy induces microsatellite instability in the peripheral blood mononuclear cells of breast cancer patients |
Q34119730 | TCF-3, 4 protein expression correlates with beta-catenin expression in MSS and MSI-H colorectal cancer from HNPCC patients but not in sporadic colorectal cancers |
Q33815796 | The Mutator Phenotype in Cancer: Molecular Mechanisms and Targeting Strategies |
Q55341284 | The PTEN, BAX, and IGFIIR genes are mutated in endometrial atypical hyperplasia. |
Q27935158 | The Saccharomyces cerevisiae MLH3 gene functions in MSH3-dependent suppression of frameshift mutations |
Q34533276 | The mechanism of mismatch repair and the functional analysis of mismatch repair defects in Lynch syndrome |
Q36825841 | The mystery of mismatch repair deficiency: lynch or lynch-like? |
Q44628695 | The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study |
Q35745852 | The role of microsatellite instability in gastric low- and high-grade lymphoma development |
Q35904483 | The utility of immunohistochemical detection of DNA mismatch repair gene proteins. |
Q37148790 | Transcriptome analysis of copper homeostasis genes reveals coordinated upregulation of SLC31A1,SCO1, and COX11 in colorectal cancer |
Q35836674 | Tumor microsatellite instability in early onset gastric cancer |
Q24614511 | Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer |
Q26864622 | Tumor-specific microsatellite instability: do distinct mechanisms underlie the MSI-L and EMAST phenotypes? |
Q37699262 | Tumors with unmethylated MLH1 and the CpG island methylator phenotype are associated with a poor prognosis in stage II colorectal cancer patients |
Q36246500 | Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome |
Q31045418 | Why do results conflict regarding the prognostic value of the methylation status in colon cancers? The role of the preservation method |
Search more.